Blood Cancer UK Research
@BloodCancer_Res
News and information from the Research Team at Blood Cancer UK. For fundraising and general news, follow @bloodcancer_uk
Our Research Involvement Lead, Lisa, recently joined forces with Gemma @VersusArthritis to support Dr Mark Bishton in involving patients with lived experience of blood cancer & inflammatory conditions in the development of a funding app. Read all about this collaboration here 👇🏻
“We believe that meaningful research starts with meaningful involvement”. Check out this fantastic blog from @bloodcancer_uk and @VersusArthritis discussing their cross-condition collaboration ensuring lived experience shapes research: bit.ly/451c2jo
A really insightful blog from @bloodcancer_uk's policy team on what the 10-year health plan means for people with blood cancer. bloodcancer.org.uk/news/what-does…
Important news, and an area where we're already investing in...
New UK regulations announced today could be transformational for people with blood cancer. From today, hospitals can manufacture CAR T-cell therapies on site, reducing wait times and improving access to this blood cancer treatment. Our reaction👇 🔗 bloodcancer.org.uk/news/legislati…
📣 Good news! I have extended the participation age range for my dissertation to 20-30 years old! If you know someone who might be interested in taking part, please feel free to share or get in touch. @LisaWhittaker02 @trekstock @ShineCancerSupp @teensunite
New blog with @CR_UK Lead Research Nurse Anne Croudass, thanks so much for sharing @ARC_S_L #ppi #involvement #cancerresearch @RadNetCRUKCoL @KingsImaging @BloodCancer_Res arc-sl.nihr.ac.uk/news-insights/…
We're so pleased to fund early career researchers like Nisha. Funding the next generation of talent is at the core of our research strategy over the next 5 years!
So grateful and honoured to be awarded a Blood Cancer UK @BloodCancer_Res Early Career Advancement Fellowship. Excited to be involved with this fantastic charity in our shared effort to beat blood cancers. @SCICambridge bloodcancer.org.uk/news/cambridge…
Wow, what an amazing day with so many incredible speakers. You are getting us closer to the day where no-one dies from blood cancer or its treatments. Thank you all so much. #bloodcancersymposium25
"It can be greatly beneficial to involve people affected by blood cancer in your research and we can help you." We hear from @LisaWhittaker02 , our Research Involvement Lead. This is a key part of our new Research Strategy 👉bit.ly/4lCE0s7 #bloodcancersymposium25
Pleasure speaking about our MPN Discovery research project funded by Blood Cancer UK and our MOSAICC study. The study is in the processing of closing UK sites after recruiting 634 cases and 197 controls.
So why do MPNs develop? Professor Lesley Anderson @GrahamAnderLes from @aberdeenuni talks us through how she is identifying small changes in our DNA that might be responsible for causing the disease. 👉bit.ly/3IdClem #bloodcancersymposium25
Closing our treatment session we heard from Prof Terry Rabbitts and Dr Daniel Sanchez-Guzman from @ICR_London who talked us through their use of antibody engineering in their quest to develop a new treatment for T-ALL. 👉bit.ly/4nB6Evy #bloodcancersymposium25
Prof Michelle West spoke about her group's drug discovery work to target EBV blood cancer cells and leave healthy cells unscathed. 👉bit.ly/4nBMrG1 Because we need to develop new treatments that cure blood cancer for good. #bloodcancersymposium25
Next up, Dr Charlotte Graham from @KingsCollegeLon who talks us through an exciting new type of CAR-T cell therapy for myeloma. This involves a new rapid production process to produce CAR-T cells in only three days. 👉bit.ly/40I4QHh #bloodcancersymposium25
"We need to establish new targeted therapies that can replace or augment existing treatments" This afternoon we kicked off our treatment session with Prof @alex_tonks sharing his research investigating the role of ROS in AML. 👉bit.ly/4lyMY9Y #bloodcancersymposium25
"The exact immune defects that lead to PTLD are unknown" Dr Heather Long @LongLabGroup at @ImmunologyUoB tells us how she is uncovering biomarkers for PTLD, a blood cancer that can develop following a stem cell transplant. 👉bit.ly/3TtRvyq #bloodcancersymposium25
Dr Sarra Ryan @SarraRyanLab talks about her exciting new sequencing technique revealing previously hidden DNA alterations in the blood cells that cause ALL in children. 👉bit.ly/4krD0q2 #bloodcancersymposium25
"We can't reliably spot MPN using conventional methods" Dr Dan Royston is using AI techniques to improve the diagnosis of MPN. 👉bit.ly/44vcsxV Because early detection will improve outcomes for people with blood cancer. #bloodcancersymposium25
We're at the @rcpsych sharing findings from the research community about the latest in prevention, early detection and treatments. Read more about our bold new research strategy in the 🧵below!
People with blood cancer can't wait. Too many are still dying from blood cancer. And for others, the treatment can be as harsh as the disease itself. That’s why we’re launching a bold new research strategy - investing £70 million over the next five years. Here’s how 👇 1/5
Great to see so many researchers come together for a day of science and talks, on what is an exciting day for the charity as we announce we're looking to fund £70m of research over the next five years! 💪 #bloodcancersymposium25 #beatingbloodcancer
On way to @BloodCancer_Res Symposium in London with @alex_tonks & @rizzo_sian Looking forward to a day of interesting talks, but most excited about meeting some members of our patient network at our ‘Research Revealed’ event this evening @bloodcancer_uk
So why do MPNs develop? Professor Lesley Anderson @GrahamAnderLes from @aberdeenuni talks us through how she is identifying small changes in our DNA that might be responsible for causing the disease. 👉bit.ly/3IdClem #bloodcancersymposium25
Now, Professor Claire Edwards from the @UniofOxford shares insights about a link between, obesity, ageing and myeloma. Read more about how fat cells interact with 'sleepy cells', waking them up and causing the disease to return👉 bit.ly/407rOr7 #bloodcancersymposium25
